- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Rethinking DSOs: Challenging common misconceptions in modern dentistry
- WakeMed CEO says years of talks led to Atrium deal: ‘We’re the smallest health system of the competitive world now in North Carolina’
- 9 behavioral health facility and service closures, layoffs in 2026
- The new class of opioids: 4 things to know
- Maine health system unveils unified brand
- Physicians in Congress propose Medicare payment overhaul
- 2 men sentenced in $522M fraud, kickback scheme
- What 3 ASC leaders are saying about cardiology’s race to outpatient
- Hospital at home linked to better outcomes: 7 notes
- Long-established Florida physician practice acquired
- Facilitating Access to Trump Accounts
- HCA Tennessee hospital taps COO
- WellSpan Health to open 4-room ASC in Pennsylvania
- Colorado hospital names new CEO
- Yale New Haven hospital president to retire
- Ascension Tennessee hospital names COO
- Nurses fret AI overreliance could erode care, call for more guardrails
- ‘Dynamics we haven’t experienced before’: Hospitals absorb costs as patients lose coverage, skip Medicaid
- Fatality risk grows 8% per added med-surg nurse patient: Study
- Surgery Partners increases same-facility revenue by 4% in Q1: 10 notes
- Fixing Failures to Communicate
- Dr. Nisha D’Silva installed as president of the American Association for Dental, Oral and Craniofacial Research
- PDS Health, CareQuest partner to expand blood pressure screenings in dental offices
- 5 hospitals, health systems investing in ASCs
- Bankruptcy, PE debt and a $3.9B Ascension deal: A 30-year breakdown of AmSurg
- Henry Schein increases global dental sales by 9% in Q1: 7 notes
- Heartland Dental expands in 7 states
- Ohio woman charged with practicing unlicensed dentistry
- 15 physician deals in 40 days
- Psych hospital eases security tool restrictions after violent incidents
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- TriHealth hospital hit with $10M verdict in psychiatric unit death
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- From 1st-in-state to 1st-in-world: 5 surgical milestones to know
- 3 dental mergers, acquisitions in April
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- HHS outlines plan to ‘curb psychiatric overprescribing’: 5 things to know
- Former Oklahoma dental assistant sentenced to prison for assaulting patients
- Statement on Proposing Semiannual Reporting
- Transforming Behavioral Healthcare Delivery through the Collaborative Care Model
- Wellstar partners with BD to implement AI-driven medication management system
- Tennessee dental practice to close due to financial strain
- Listen to the Latest ‘KFF Health News Minute’
- Lifepoint Health taps new vice president of finance from Acadia
- UnitedHealthcare to reduce prior auth requirements by 30%
- ‘Retire one-and-done interventions’: Wellstar achieves 40% drop in physician distress
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
- CVS to expand biosimilar formulary adoptions to improve affordability, accessibility
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Novartis to close German manufacturing site, cutting 220 jobs
- BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- Sanofi expands AI capabilities, investing $294M to scale Toronto hub
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Assort Health rolls out outbound AI agent for personalized patient outreach
- Neurocrine cites work disruption data to make case for timely movement disorder diagnosis
- Eyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO
- Newly formed Keenova launches ‘Don't Be a Viking’ campaign for Dupuytren’s contracture
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial
- Why state dental boards are scrutinizing DSOs
- Child Mind Institute names chief clinical officer
- UMass Memorial behavioral health provider to lay off 78 employees
- Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform
- Healthcare Dealmakers—UConn Health grows, Centene subsidiaries merge and more
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- American Hospital Association, West Health Institute partner to help health systems scale new tech
- Alignment CEO expects short delay for CMS' proposed risk adjustment changes
- WakeMed Health's plans to join Atrium Health face swift pushback from NC officials
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- SCOTUS temporarily restores online access to abortion pill after appeals court ruling
- SCOTUS temporarily restores online access to abortion pill after appeals court ruling
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Nearly half of reproductive age women with Medicaid coverage live in states restricting abortion: KFF
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- CDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike
- After March cuts, Novartis trims another 60 roles at US headquarters
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion
- Journalists Share Latest on Baby Formula Safety, Estrogen Patches, and Postcancer Costs
- Prevention Efforts Increasingly See Suicide Through a Broader Lens
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Industry Voices—Value-based care won the policy argument. Now it has to deliver
- Senators introduce clean extension to cost-based payments for some rural hospitals
- Beth Israel Lahey Health taps Heidi for system-wide AI scribe rollout
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Cleveland Clinic taps startup Luminai to test how AI can run hospital operations
- Look out Rexulti, Axsome's Auvelity has its nod for Alzheimer's agitation
- Cardio drug developer Esperion to go private in potential $1.1B buyout by ArchiMed
- Union workers at Korean CDMO Samsung Biologics kick off strike
- Summit's PD-1xVEGF interim trial miss surprises analysts, shares tumble
- Health Tech Weekly Rundown: Sage launches Tasking for senior care workflows; St. Luke’s taps Auxira Health for cardiologist support
- Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds
- Senses, Not Muscles, Key to Speech Recovery After Stroke
- Antibiotics Not Linked To Celiac Disease Risk, Study Argues
- Common Knee Surgery Doesn't Help, Might Actually Make Things Worse, Clinical Trial Reports
- States Rush To Figure Out How To Enforce Trump's Medicaid Work Requirements
- Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits
- Delays in Visa Program Threaten Placement of Hundreds of Doctors in Underserved Areas
- FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug Daraxonrasib
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- Managing AI in Medical Technology: From Innovation to Compliance
- Managing AI in Medical Technology: From Innovation to Compliance
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- New Medical Guidelines Urge More Fiber, Less Bathroom Scrolling on Your Phone
- Sleep and Anxiety Medications in Pregnancy Appear to Pose Little Harm
- Trump's Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Nasal Spray Flu Vaccines Create 'Battlefield' In Adults' Noses
- Prehabilitation Slashes Post-Op Complications By Half, Review Says
- Understanding Emotions Could Be Key To Quelling Chronic Pain
- Meth Caused 1 In 6 Heart Attacks Over A Decade, Study Finds
- Rising Stars: Axplora’s Arsalan Khan gets technical on marketing
- Orchestrating Affordability: The Critical New Role of the Health Plan
- The Case for a More Proactive Payment Integrity Program
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
This is outright Stalinism. The Biden Administration Department of Justice conspired with pro abortion groups to track pro-life activists’ First Amendment activity and then incarcerate them using the Freedom of Access to Clinic Entrances (FACE) Act:
https://www.justice.gov/opa/media/1436006/dl
Justice Department Reveals the Biden Administration’s Weaponization of Federal Law Against Pro-Life Americans
For Immediate Release - Tuesday, April 14, 2026
DoJ Office of Public AffairsDOJ Weaponization Working Group Report Outlines Corrective Action Taken to Restore the Public’s Confidence in Lawful Treatment of All Americans
Today, the Justice Department’s Weaponization Working Group published a report detailing the Biden Administration’s weaponization of the Freedom of Access to Clinic Entrances (FACE) Act. Based on a review of over 700,000 internal records, the report not only details specific ways the Biden Justice Department weaponized federal law, but also outlines the corrective action taken by the current Justice Department to make right the wrongs of the prior administration.
“This Department will not tolerate a two-tiered system of justice,” said Acting Attorney General Todd Blanche. “No Department should conduct selective prosecution based on beliefs. The weaponization that happened under the Biden Administration will not happen again, as we restore integrity to our prosecutorial system.”
President Trump promised to end the weaponization of the federal government. To many Americans, prosecutions under the FACE Act have been the prototypical example of this weaponization. The Justice Department conducted a thorough review of internal discussions, case files, and prosecutorial decisions under the Act and concludes that the Biden DOJ weaponized the FACE Act in several ways.
- The Biden DOJ closely collaborated with pro-abortion groups to track pro-life activists’ First Amendment activity. Pro-abortion groups—especially the National Abortion Federation, Planned Parenthood, and Feminist Majority Foundation—capitalized on their relationship with the Biden DOJ to gain internal information and push targets for enforcement. These groups compiled evidence and dossiers that ultimately gave rise to search warrants and charges. The Biden DOJ affirmatively asked pro-abortion groups about pro-life individuals’ travel and constitutionally protected advocacy. The Biden DOJ and career attorneys monitored pro-life activists for years before charging them.
- The Biden DOJ’s prosecutors engaged in inappropriate conduct and comments. Prosecutors knowingly withheld evidence that defense counsel requested to prepare an affirmative defense, tried to screen out jurors based on religion, and authorized aggressive arrest tactics instead of allowing pro-life defendants to self-surrender.
- The Biden DOJ helped a pro-abortion group secure funding. The lead prosecutor on each FACE Act prosecution served as a reference on the National Abortion Federation’s application for a private grant. We found no record of ethics approval for the attorney to take an interest in the financial outcome of a party having business before the Biden DOJ.
- The Biden DOJ pursued significantly harsher sentences for pro-life defendants than violent pro-abortion defendants. The Biden DOJ requested an average sentence of 26.8 months for pro-life defendants, compared to 12.3 months for pro-abortion defendants.
- The Biden DOJ violated the rights of Americans through its biased enforcement of the FACE Act. Though the Act was supposed to protect both pro-choice and pro-life facilities, the Biden DOJ provided extensive support to abortion clinics, while ignoring and downplaying vandalism and attacks against pregnancy resource centers.
The Biden DOJ’s actions were wrong. The Trump Administration and Acting Attorney General Todd Blanche are committed to rectifying these wrongs by taking the following actions.
- On January 23, 2025, President Trump issued full and unconditional pardons to many of the pro-life Christians unfairly targeted by the Biden DOJ.
- DOJ has settled civil cases to address the injustices and took personnel action against those responsible.
- DOJ leadership has dismissed, with prejudice, three civil lawsuits against pro-life activists: United States v. Connolly, No. 2:24-cv-04467 (E.D. Penn.); United States v. Zastrow, et al., No. 2:24-cv-00576 (M.D. Fla.); United States v. Citizens for a Pro-Life Society, et al., No. 1:24-cv-00893 (N.D. Ohio).
- The Trump DOJ issued a directive that, moving forward, DOJ prosecutors may only bring abortion-related civil actions and prosecutions under the FACE Act in extraordinary circumstances or in cases presenting significant aggravating factors.
- To prepare this report, DOJ reviewed approximately 700,000 internal records. Acting Attorney General Blanche has approved a limited waiver of privileged information to provide the public the opportunity to review the underlying materials.
“The behavior unearthed in this report is shameful,” said Assistant Attorney General Daniel Burrows, Office of Legal Policy. “Lawyers who should have known better withheld evidence, worked to keep committed religious people off juries, and generally allowed the Department of Justice to be used as the enforcement arm of pro-abortion special interests.”
DOJ is committed to prosecuting crime in a manner that is consistent with its mission to uphold the rule of law, to keep our country safe, and to protect civil rights. Should other affected individuals have concerns, DOJ will assess their allegations without fear or favor.
You can find the report and over 800 pages of exhibits here.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














